Originally Posted by Vteckidd
No but they have already established cash flow and are selling products, so its a whole different story and a hell lot less risky than something like LLBO that is in huge debt from developing their technology without any income in over a decade.
LLBO also has no pipeline of products, only different applications (breast cancer, ovarian cancer) of the same technology. In other words they have all their eggs in one basket ( impossible for a biotech/pharma company to get any financing with this strategy, Im guessing this is the reason they went public so early)
Well the whole circadian pattern thing is pretty interesting, but you can read on their website that they sold the IP rights to another company a few years ago (did they give up? or was the offer just too good to pass up? who knows). The company that bought the technology had it for 2 years and did absolutely nothing with it, and ended up selling it back to LLBO because "it wanted to focus on other things". Kinda strange.
They also definitely don't have the resources to mass produce their device if it does get FDA approved. So maybe they will sell off the technology again, get bought out, or partner with a larger diagnostics company like BD, but that part is easy once the device is approved/works as well as they say and can be sold profitably.
Reply With Quote